MedPath

Traditional Chinese medicine in the treatment of systemic lupus erythematosus: a prospective cohort study

Not Applicable
Recruiting
Conditions
Systemic lupus erythematosus
Registration Number
ITMCTR2000003114
Lead Sponsor
The Second Affiliated Hospital of Zhejiang Chinese Medicine University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Conforms to the SLE classification standard formulated by SLICC in 2009;
2. Aged between 14 and 65;
3. The patient was informed and agreed to participate in the study.

Exclusion Criteria

1. Patients with end-stage renal disease, grade IV heart failure (NYHA classification), liver failure, sepsis, and malignant tumors;
2. Patients with severe or poorly controlled hypertension (SBP >= 160mmHg or DBP>= 90mmHg) or diabetes (HbA1c> 8%);
3. Schizophrenia or other mental illness patients who cannot fully recognize their behavior;
4. Pregnant or lactating women.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.